The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seyfert, V. L.
Right arrow Articles by Monroe, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seyfert, V. L.
Right arrow Articles by Monroe, J. G.

The Journal of Immunology, Vol 145, Issue 11 3647-3653, Copyright © 1990 by American Association of Immunologists


ARTICLES

Egr-1 expression in surface Ig-mediated B cell activation. Kinetics and association with protein kinase C activation

VL Seyfert, S McMahon, W Glenn, XM Cao, VP Sukhatme and JG Monroe
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104-6082.

We have studied the expression of an immediate/early type gene, Egr-1, in murine B lymphocyte responses to Ag receptor-generated signals. The Egr-1 gene encodes a zinc finger protein with sequence-specific DNA binding activity and is believed to act as an intracellular "third messenger," to couple receptor-generated signals to activation- associated changes in gene expression. We show here that Egr-1 mRNA expression is rapidly and transiently (returning to basal levels by 6 h) induced after receptor crosslinking with anti-receptor antibodies. Egr-1 protein expression is more prolonged, maintaining detectable levels through 12 h. The induction of Egr-1 is a primary response to Ag receptor signaling, as it is independent of new protein synthesis and is inhibited by actinomycin D. We have also examined the linkage of Egr- 1 to known signaling pathways associated with G0 to G1 transition by these cells in response to signals generated through the B cell Ag receptor. Egr-1 mRNA was not induced after elevation of intracellular free Ca2+. In contrast, the pharmacologic agents PMA and SC-9, which directly activate protein kinase C, both cause marked increases in Egr- 1 mRNA levels with the same kinetics as observed after anti-receptor antibody stimulation. Further, the protein kinase C inhibitors H7, sangivamycin, and staurosporin block anti-receptor antibody-induced expression of Egr-1, thus, B cell Ag receptor-linked Egr-1 expression is likely coupled to the protein kinase C component of transmembrane signaling. Preliminary promoter mapping studies are consistent with this conclusion, because both PMA and anti-receptor antibody act through the same or overlapping cis-regulatory elements.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. Ke, M. Gururajan, A. Kumar, A. Simmons, L. Turcios, R. L. Chelvarajan, D. M. Cohen, D. L. Wiest, J. G. Monroe, and S. Bondada
The Role of MAPKs in B Cell Receptor-induced Down-regulation of Egr-1 in Immature B Lymphoma Cells
J. Biol. Chem., December 29, 2006; 281(52): 39806 - 39818.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Singh, J. Svaren, J. Grayson, and M. Suresh
CD8 T Cell Responses to Lymphocytic Choriomeningitis Virus in Early Growth Response Gene 1-Deficient Mice
J. Immunol., September 15, 2004; 173(6): 3855 - 3862.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Gee, W. Lim, W. Ma, D. Nandan, F. Diaz-Mitoma, M. Kozlowski, and A. Kumar
Differential Regulation of CD44 Expression by Lipopolysaccharide (LPS) and TNF-{alpha} in Human Monocytic Cells: Distinct Involvement of c-Jun N-Terminal Kinase in LPS-Induced CD44 Expression
J. Immunol., November 15, 2002; 169(10): 5660 - 5672.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Swart, D. M. Bergeron, and T. C. Chiles
Identification of a Membrane Ig-Induced p38 Mitogen-Activated Protein Kinase Module That Regulates cAMP Response Element Binding Protein Phosphorylation and Transcriptional Activation in CH31 B Cell Lymphomas
J. Immunol., March 1, 2000; 164(5): 2311 - 2319.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Tanguay, S. Pavlovic, M. J. Piatelli, J. Bartek, and T. C. Chiles
B Cell Antigen Receptor-Mediated Activation of Cyclin-Dependent Retinoblastoma Protein Kinases and Inhibition by Co-Cross-Linking with Fc{gamma} Receptors
J. Immunol., September 15, 1999; 163(6): 3160 - 3168.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. B. King, A. Norvell, and J. G. Monroe
Antigen Receptor-Induced Signal Transduction Imbalances Associated with the Negative Selection of Immature B Cells
J. Immunol., March 1, 1999; 162(5): 2655 - 2662.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Katsuta, S. Tsuji, Y. Niho, T. Kurosaki, and D. Kitamura
Cutting Edge: Lyn-Mediated Down-Regulation of B Cell Antigen Receptor Signaling: Inhibition of Protein Kinase C Activation by Lyn in a Kinase-Independent Fashion
J. Immunol., February 15, 1998; 160(4): 1547 - 1551.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Muthukkumar, S.-S. Han, S. Muthukkumar, V. M. Rangnekar, and S. Bondada
Role of Egr-1 Gene Expression in B Cell Receptor-induced Apoptosis in an Immature B Cell Lymphoma
J. Biol. Chem., October 31, 1997; 272(44): 27987 - 27993.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
H. Shao, D. H. Kono, L.-Y. Chen, E. M. Rubin, and J. Kaye
Induction of the Early Growth Response (Egr) Family of Transcription Factors during Thymic Selection
J. Exp. Med., February 17, 1997; 185(4): 731 - 744.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.